Neuraltus Pharmaceuticals, Inc.;The Regents of the University of California
发明人:
申请号:
EP15792274.1
公开号:
EP3142674A4
申请日:
2015.05.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Provided herein are methods and composition for the treatment for macrophage-related disorders, for example through the use of biomarkers for selection of responders and treatment monitoring.